官方服务：
资源简介：
Impact of Verteporfin on HCC cells
应用场景：
创建时间：
2016-02-11
相关数据集
North America Hepatocellular Carcinoma Drugs Market
The North America Hepatocellular Carcinoma Drugs report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into ca
IMR REPORTS40
Data.
Hepatocellular carcinoma (HCC) remains lethal despite multitargeted tyrosine kinase inhibitors and immunotherapy, motivating the repurposing of safe, widely available agents. To delineate the anti-HCC
NIAID Data Ecosystem20
DataSheet1_Morpholinyl silicon phthalocyanine nanoparticles with lysosome cell death and two-photon imaging functions for in vitro photodynamic therapy of cancer cells.doc
The lysosome is an important target for realizing antitumor therapy. Lysosomal cell death exerts significant therapeutic effects on apoptosis and drug-resistance. The development of lysosome-targeting
NIAID Data Ecosystem10
DataSheet1_Dioscorea Zingiberensis New Saponin Inhibits the Growth of Hepatocellular Carcinoma by Suppressing the Expression of Long Non-coding RNA TCONS-00026762.ZIP
Background: The etiology and carcinogenesis of hepatocellular carcinoma (HCC) are associated with various risk factors. Saponins extracted from Dioscorea zingiberensis C. H. Wright exhibit antitumor a
NIAID Data Ecosystem20
Additional file 1 of CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
Additional file 1: Table S1. A list of genes up-regulated with fold change ≥2 in cDNA microarray analysis. Table S2. Growth inhibition rates of each treatment. Figure S1. The cytotoxic efficacy of CKD
Figshare2020-10-16 更新10
